European Archives - Page 670 of 1062 - European Medical Journal

Continue
1 Mins
29 Jul 2019

Comparison of PAXgene and Tempus Whole Blood RNA Collection and Isolation Systems for the Quantification of Type I Interferon-Stimulated Gene Expression

Type I IFN have important roles in many paediatric and adult rheumatic diseases and are a new therapeutic target for which several anti-IFN treatments…
10 Mins
29 Jul 2019

Fine-Tuning the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway

The aim of this symposium was to familiarise participants with the IL-23 pathway and the rationale for targeting this pathway in PsA…
9 Mins
29 Jul 2019

Editor’s Pick: Immunometabolism in Rheumatic Disease: The Role in Pathogenesis and Implications for Treatment

The field of immunometabolism is a rapidly expanding area of research that centres around understanding the interrelationship between immunological and…
1 Mins
29 Jul 2019

Effects of Successive Switches to Different Biosimilars Infliximab on Immunogenicity in Chronic Inflammatory Diseases in Daily Clinical Practice

Immunogenicity constitutes an important concern since it is associated with lower clinical responses and more adverse events…
10 Mins
29 Jul 2019

Postmenopausal Osteoporosis: A Mini Review

Osteoporosis is a systemic skeletal disease characterised by microarchitectural deterioration and high fragility of bone tissue, resulting in low bone…
11 Mins
29 Jul 2019

Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome

Although aPL are reported in 1–5% of the general population,2 only a minority of these individuals will develop the clinical manifestations of APS. The incidence of APS…
11 Mins
29 Jul 2019

Secukinumab in the Management of Psoriatic Arthritis: Current Perspectives

Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…
8 Mins
29 Jul 2019

A Review of Adalimumab Biosimilars for the Treatment of Immune-Mediated Rheumatic Conditions

Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…
5 Mins
29 Jul 2019

Real-World Experience of Apremilast in Treating Psoriatic Arthritis Patients with Comorbidities

Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…
23 Jul 2019

Progress In Understanding Endometriosis

PELVIC pain in women with endometriosis may be caused primarily by a type of white blood cell called macrophages that have been modified because…